1. Biblio

Biblio

Found 4 results
Author Title [ Type(Desc)] Year
Filters: Keyword is Tetrachlorodibenzodioxin  [Clear All Filters]
Journal Article
C. J. Funatake, Marshall, N. B., Steppan, L. B., Mourich, D. V., and Kerkvliet, N. I., “Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cells.”, J Immunol, vol. 175, no. 7, pp. 4184-8, 2005.
J. - Y. Choi, Oughton, J. A., and Kerkvliet, N. I., “Functional alterations in CD11b(+)Gr-1(+) cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.”, Int Immunopharmacol, vol. 3, no. 4, pp. 553-70, 2003.
N. I. Kerkvliet, “Recent advances in understanding the mechanisms of TCDD immunotoxicity.”, Int Immunopharmacol, vol. 2, no. 2-3, pp. 277-91, 2002.
C. Weiss, Faust, D., Dürk, H., Kolluri, S., Pelzer, A., Schneider, S., Dietrich, C., Oesch, F., and Göttlicher, M., “TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway.”, Oncogene, vol. 24, no. 31, pp. 4975-83, 2005.